These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10633052)

  • 61. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
    Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
    Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Respiratory physio-kinesitherapy in cystic fibrosis: the parents' viewpoint].
    Battistini A; Grzincich GL; Pisi G; Bocchi U; Marvasi R; Costantini D; Antonelli M; Castello D; Cappelletti LM; Nantron M
    Pediatr Med Chir; 1988; 10 Suppl 1():1-14. PubMed ID: 3222163
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF).
    Nagano Y; Millar BC; Goldsmith CE; Walker JM; Elborn JS; Rendall J; Moore JE
    J Cyst Fibros; 2008 Nov; 7(6):566-72. PubMed ID: 18723404
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of throat swabs and nasopharyngeal suction specimens in non-sputum-producing patients with cystic fibrosis.
    Taylor L; Corey M; Matlow A; Sweezey NB; Ratjen F
    Pediatr Pulmonol; 2006 Sep; 41(9):839-43. PubMed ID: 16850448
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Microbial contamination of domiciliary nebuliser therapy equipment.
    Jones PD; Moritz V; Pierce RJ
    Aust N Z J Med; 1985 Oct; 15(5):585-9. PubMed ID: 3867335
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Familial concordance of phenotype and microbial variation among siblings with CF.
    Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E
    Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods.
    Pressler T; Karpati F; Granström M; Knudsen PK; Lindblad A; Hjelte L; Olesen HV; Meyer P; Høiby N;
    J Cyst Fibros; 2009 Jan; 8(1):37-42. PubMed ID: 18835753
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Microbial colonization of nebulizers used by asthmatic children.
    Cohen HA; Kahan E; Cohen Z; Sarrell M; Beni S; Grosman Z; Ashkenazi S
    Pediatr Int; 2006 Oct; 48(5):454-8. PubMed ID: 16970782
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pseudomonas aeruginosa diversity in distinct paediatric patient groups.
    Tramper-Stranders GA; van der Ent CK; Wolfs TF; Kimpen JL; Fleer A; Johansen U; Johansen HK; Høiby N
    Clin Microbiol Infect; 2008 Oct; 14(10):935-41. PubMed ID: 18752596
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Importance of Nebulizer Drying for Patients With Cystic Fibrosis.
    Moore JE; Moore RE; Bell J; Millar BC
    Respir Care; 2020 Oct; 65(10):1443-1450. PubMed ID: 32209705
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
    Manno G; Cruciani M; Romano L; Scapolan S; Mentasti M; Lorini R; Minicucci L
    Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RISA-HPLC analysis of lung bacterial colonizers of cystic fibrosis children.
    Nazaret S; Assade F; Brothier E; Freydière AM; Bellon G; Cournoyer B
    J Microbiol Methods; 2009 Jan; 76(1):58-69. PubMed ID: 18929602
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Water filters can prevent Stenotrophomonas maltophilia contamination of nebuliser equipment used by people with cystic fibrosis.
    Woodhouse R; Peckham DG; Conway SP; Denton M
    J Hosp Infect; 2008 Apr; 68(4):371-2. PubMed ID: 18353498
    [No Abstract]   [Full Text] [Related]  

  • 75. Pseudomonas aeruginosa in cystic fibrosis: cross-infection and the need for segregation.
    Tubbs D; Lenney W; Alcock P; Campbell CA; Gray J; Pantin C
    Respir Med; 2001 Feb; 95(2):147-52. PubMed ID: 11217911
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Aerosol therapy and cystic fibrosis: a national survey].
    Huet F; Nivelon JL
    Rev Pneumol Clin; 1997; 53(2):91-7. PubMed ID: 9205688
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Lebecque P; Leal T; Zylberberg K; Reychler G; Bossuyt X; Godding V
    J Cyst Fibros; 2006 Dec; 5(4):237-44. PubMed ID: 16790367
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mist tent therapy of the obstructive pulmonary lesion of cystic fibrosis.
    Matthews LW; Doershuk CF; Spector S
    Pediatrics; 1967 Feb; 39(2):176-85. PubMed ID: 6017955
    [No Abstract]   [Full Text] [Related]  

  • 79. Cleaning small-volume nebulizers: the efficacy of different reagents and application methods.
    Tai CH; Lin NT; Peng TC; Lee RP
    J Nurs Res; 2011 Mar; 19(1):61-7. PubMed ID: 21350388
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Bacterial contamination of the apparatus for hygrothermal inhalations, of the mineral water aerosol and of the compressed air used for inhalations].
    Khinchagov BP; Korosteleva MK
    Vopr Kurortol Fizioter Lech Fiz Kult; 1993; (5):63-5. PubMed ID: 8266676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.